Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricSTESterisZBHZimmer BiometDXCMDexcom
Snapshot
Price$234.11$96.12$83.47
Market cap$21.27B$17.28B$27.49B
Valuation
P/E29.2x24.4x34.9x
Forward P/E22.8x28.6x25x
Growth
Revenue growth8.7%9.2%16.1%
EPS growth27.9%-14.6%77.5%
Profitability
Net margin13.2%9.1%19.3%
ROE11.1%6.0%33.8%
Balance sheet & cash
Debt / equity0.27x0.59x0.47x
Free cash flow yield5.4%7.5%1.8%
Dividend yield1.2%1.0%—
Verdict
Investment ratingFavorable· 59Neutral· 50Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearSTEtoday $234ZBHtoday $96DXCMtoday $83
2027$224.66 – $329.50+41% CAGR$73.53 – $107.85+12% CAGR$111.09 – $162.93+95% CAGR
2028$287.45 – $421.59+34% CAGR$75.00 – $110.00+7% CAGR$197.13 – $289.12+86% CAGR
2029$367.79 – $539.43+32% CAGR$76.50 – $112.20+5% CAGR$349.80 – $513.04+83% CAGR
2030$470.59 – $690.20+31% CAGR$78.03 – $114.45+4% CAGR$620.72 – $910.39+82% CAGR
2031$602.12 – $883.11+30% CAGR$79.59 – $116.74+4% CAGR$1,101.47 – $1,615.49+81% CAGR
5-yr CAGR20.8% – 30.4%-3.7% – 4.0%67.5% – 80.9%